Fiji vs Malaysia: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Fiji
92.0%
in 2025
Malaysia
93.0%
in 2025
Fiji rank
56th
Malaysia rank
53rd
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Fiji
- Malaysia
How they compare
Malaysia currently reports 93.0% against 92.0% in Fiji, a difference of 1.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Malaysia ahead.
Fiji ranks 56th and Malaysia ranks 53rd of 194 countries.
Fiji has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Fiji | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | β |
| 2010s | 65.8% | 0.0% | 65.8% | Fiji |
| 2020s | 95.0% | 73.3% | 21.7% | Fiji |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Fiji or Malaysia?
- Malaysia, at 93.0% against 92.0% in Fiji as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Fiji and Malaysia?
- 1.0%, with Malaysia ahead.
- How many years of comparable data are there for Fiji and Malaysia?
- 18 years are reported by both, from 2008 to 2025.
- How do Fiji and Malaysia rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Fiji ranks 56th and Malaysia ranks 53rd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.